Pharmaceutical companies

Design more successful, cost effective and faster clinical trials

We deliver Real-World Imaging Datasets

  • We transform raw data from hospitals into homogeneous high-quality regulatory-grade datasets for your research projects.

 

  • We source data (imaging data, clinical data, biology, radiology reports, oncology notes...) from our network of European hospital partners and international data partners, taking into account criteria such as type of exams, specificity, quality and volume to meet your specific cohort needs.

 

  • Our solution allows us to select, extract, de-identify, harmonize, curate, enrich and route large amounts of data.

 

  • We set up the technical and contractual framework between the data provider, Medexprim and the data user.

We build Data Lakes by disease

  • We aim to build multi-centric and multi-omic data lakes by disease (e.g. rare diseases, lung, breast, colorectal, melanoma, leukemia, prostate cancers).

 

  • We see data lakes as living organisms that will be continuously fed and enriched with new data, allowing for biostatistics and sophisticated analytics, AI development for biomarkers, diagnosis and prognosis.

uses

  • Data for trial efficiency: early clinical trial assessments, patient identification, patient recruitment, cohort optimization and patient stratification, synthetic control arms for virtual or hybrid trials

 

  • Imaging Biomarkers: ad-hoc developments, state of the art integration with best-in-class partners at scale.

 

  • Data for reimbursement and commercialization strategies: disease detection and hidden patients identification, label expansion and off-label usage understanding/mitigation, ad-hoc support to regulatory submissions, epidemiology studies and post marketing registries, imaging biomarkers for value-based engagements with payers, additional analyses for regulatory, payer and competitive differentiation purposes.

benefits

  • Reduced timeline of patient recruitment and costs for all clinical trial phases

 

  • Response to the most specific cohort needs and access to the exact target patients

 

  • Long-term multi-centric partnerships with European hospitals, for easy access to homogeneous high-quality regulatory-grade data

 

  • Business Intelligence processes, data management tools

 

  • Productivity gain

 

  • Security, patient anonymity and GDPR compliance.
Interested in a partnership?
testimonial-4

“Medexprim pitched a cutting-edge solution that meets the core aim of the Pistoia Alliance – to lower the barriers which hamper innovation in life sciences R&D. It embodies the dynamism and entrepreneurship that is a vital part of the life sciences industry. Collecting and analysing both structured and unstructured big data, presents a significant challenge to the industry. Meeting this challenge will demand the kind of innovative solutions that Medexprim has developed. In collaboration with the rest of the industry, innovators such as Medexprim will be essential in helping the life sciences community unlock the value of the data it produces.”

Dr Steve Arlington

-

President of the Pistoia Alliance

Toulouse - Paris - London - Boston

815 La Pyrénéenne, 31670 Labège

+33 (0) 5 31 61 59 70

Linkedin
Youtube-square

Legal Notices

Support for users

Contact Medexprim

Copyright® 2021 — Medexprim